神経病理学分野

182  件  
※ 登録方法の違いにより重複して表示されている場合があります。

  1. Homma H, Yoshioka Y, Fujita K, Shirai S, Hama Y, Komano H, Saito Y, Yabe I, Okano H, Sasaki H, Tanaka H, Okazawa H: Dynamic molecular network analysis of iPSC-Purkinje cells differentiation delineates roles of ISG15 in SCA1 at the earliest stage. Commun Biol. 2024.04; 7 (1): 413. ( PubMed , DOI )

  2. Homma H, Tanaka H, Fujita K, Okazawa H: Necrosis Links Neurodegeneration and Neuroinflammation in Neurodegenerative Disease. Int J Mol Sci. 2024.03; 25 (7): 3636. ( PubMed , DOI )

  1. Yoshioka Y, Taniguchi JB, Homma H, Tamura T, Fujita K, Inotsume M, Tagawa K, Misawa K, Matsumoto N, Nakagawa M, Inoue H, Tanaka H, Okazawa H: AAV-mediated editing of PMP22 rescues Charcot-Marie-Tooth disease type 1A features in patient-derived iPS Schwann cells. Commun Med (Lond). 2023.11; 3 (1): 170. ( PubMed , DOI )

  2. Gall-Duncan T, Luo J, Jurkovic CM, Fischer LA, Fujita K, Deshmukh AL, Harding RJ, Tran S, Mehkary M, Li V, Leib DE, Chen R, Tanaka H, Mason AG, Lévesque D, Khan M, Razzaghi M, Prasolava T, Lanni S, Sato N, Caron MC, Panigrahi GB, Wang P, Lau R, Castel AL, Masson JY, Tippett L, Turner C, Spies M, La Spada AR, Campos EI, Curtis MA, Boisvert FM, Faull RLM, Davidson BL, Nakamori M, Okazawa H, Wold MS, Pearson CE: Antagonistic roles of canonical and Alternative-RPA in disease-associated tandem CAG repeat instability. Cell. 2023.10; 186 (22): 4898-4919.e25. ( PubMed , DOI )

  3. Fujita K, Homma H, Jin M, Yoshioka Y, Jin X, Saito Y, Tanaka H, Okazawa H: Mutant α-synuclein propagates via the lymphatic system of the brain in the monomeric state. Cell Rep. 2023.08; 42 (8): 112962. ( PubMed , DOI )

  4. Shiwaku H, Katayama S, Gao M, Kondo K, Nakano Y, Motokawa Y, Toyoda S, Yoshida F, Hori H, Kubota T, Ishikawa K, Kunugi H, Ikegaya Y, Okazawa H, Takahashi H: Analyzing schizophrenia-related phenotypes in mice caused by autoantibodies against NRXN1α in schizophrenia. Brain Behav Immun. 2023.07; 111 32-45. ( PubMed , DOI )

  5. Maiko Inotsume, Tomoki Chiba, Takahide Matsushima, Ryota Kurimoto, Mitsuyo Nakajima, Tomomi Kato, Kana Shishido, Lin Liu, Koichi Kawakami, Hiroshi Asahara: One-step generation of mice with gene editing by Tol2 transposon-dependent gRNA delivery. FEBS Lett. 2023.03; ( PubMed , DOI )

  6. Jin X, Tanaka H, Jin M, Fujita K, Homma H, Inotsume M, Yong H, Umeda K, Kodera N, Ando T, Okazawa H: PQBP5/NOL10 maintains and anchors the nucleolus under physiological and osmotic stress conditions. Nat Commun. 2023.01; 14 (1): 9. ( PubMed , DOI )

  7. Hiroto Yamamoto, Yutaro Uchida, Ryota Kurimoto, Tomoki Chiba, Takahide Matsushima, Yoshiaki Ito, Maiko Inotsume, Kohei Miyata, Kenta Watanabe, Masaki Inada, Naoki Goshima, Tokujiro Uchida, Hiroshi Asahara: RNA-binding protein LIN28A upregulates transcription factor HIF1α by posttranscriptional regulation via direct binding to UGAU motifs. J Biol Chem. 2023.01; 299 (1): 102791. ( PubMed , DOI )

  1. Yuta Fujii, Lin Liu, Lisa Yagasaki, Maiko Inotsume, Tomoki Chiba, Hiroshi Asahara: Cartilage Homeostasis and Osteoarthritis. Int J Mol Sci. 2022.06; 23 (11): ( PubMed , DOI )

  2. Tanaka H, Okazawa H: PQBP1: The Key to Intellectual Disability, Neurodegenerative Diseases, and Innate Immunity. Int J Mol Sci. 2022.06; 23 (11): 6227. ( PubMed , DOI )

  3. Shiwaku H, Katayama S, Kondo K, Nakano Y, Tanaka H, Yoshioka Y, Fujita K, Tamaki H, Takebayashi H, Terasaki O, Nagase Y, Nagase T, Kubota T, Ishikawa K, Okazawa H, Takahashi H: Autoantibodies against NCAM1 from patients with schizophrenia cause schizophrenia-related behavior and changes in synapses in mice. Cell Rep Med. 2022.04; 3 (4): 100597. ( PubMed , DOI )

  1. Okazawa H, Tanaka H: Molecular Dissection and Therapeutic Application of SCA1 Pathologies Revealed by Comprehensive Approaches. Cerebellum as a CNS Hub. 2021.11; 479-486.

  2. Jin M, Shiwaku H, Tanaka H, Obita T, Ohuchi S, Yoshioka Y, Jin X, Kondo K, Fujita K, Homma H, Nakajima K, Mizuguchi M, Okazawa H: Tau activates microglia via the PQBP1-cGAS-STING pathway to promote brain inflammation. Nat Commun. 2021.11; 12 (1): 6565. ( PubMed , DOI )

  3. Tanaka H, Kondo K, Fujita K, Homma H, Tagawa K, Jin X, Jin M, Yoshioka Y, Takayama S, Masuda H, Tokuyama R, Nakazaki Y, Saito T, Saido T, Murayama S, Ikura T, Ito N, Yamamori Y, Tomii K, Bianchi ME, Okazawa H: HMGB1 signaling phosphorylates Ku70 and impairs DNA damage repair in Alzheimer's disease pathology. Commun Biol. 2021.10; 4 (1): 1175. ( PubMed , DOI )

  4. Jin M, Jin X, Homma H, Fujita K, Tanaka H, Murayama S, Akatsu H, Tagawa K, Okazawa H: Prediction and verification of the AD-FTLD common pathomechanism based on dynamic molecular network analysis. Commun Biol. 2021.08; 4 (1): 961. ( PubMed , DOI )

  5. Kondo K, Ikura T, Tanaka H, Fujita K, Takayama S, Yoshioka Y, Tagawa K, Homma H, Liu S, Kawasaki R, Huang Y, Ito N, Tate SI, Okazawa H: Hepta-Histidine Inhibits Tau Aggregation. ACS Chem Neurosci. 2021.08; 12 (16): 3015-3027. ( PubMed , DOI )

  6. Yoshiaki Ito, Tokio Matsuzaki, Fumiaki Ayabe, Sho Mokuda, Ryota Kurimoto, Takahide Matsushima, Yusuke Tabata, Maiko Inotsume, Hiroki Tsutsumi, Lin Liu, Masahiro Shinohara, Yoko Tanaka, Ryo Nakamichi, Keiichiro Nishida, Martin K Lotz, Hiroshi Asahara: Both microRNA-455-5p and -3p repress hypoxia-inducible factor-2α expression and coordinately regulate cartilage homeostasis. Nat Commun. 2021.07; 12 (1): 4148. ( PubMed , DOI )

  7. Homma H, Tanaka H, Jin M, Jin X, Huang Y, Yoshioka Y, Bertens CJ, Tsumaki K, Kondo K, Shiwaku H, Tagawa K, Akatsu H, Atsuta N, Katsuno M, Furukawa K, Ishiki A, Waragai M, Ohtomo G, Iwata A, Yokota T, Inoue H, Arai H, Sobue G, Sone M, Fujita K, Okazawa H: DNA damage in embryonic neural stem cell determines FTLDs' fate via early-stage neuronal necrosis. Life Sci Alliance. 2021.06; 4 (7): e202101022. ( PubMed , DOI )

  8. Hitoshi Okazawa: Intracellular amyloid hypothesis for ultra-early phase pathology of Alzheimer's disease. Neuropathology. 2021.04; 41 (2): 93-98. ( PubMed , DOI )

  9. Saito M, Nakayama M, Fujita K, Uchida A, Yano H, Goto S, Okazawa H, Sone M: Role of the Drosophila YATA protein in the proper subcellular localization of COPI revealed by in vivo analysis. Genes Genet Syst. 2021.03; 95 (6): 303-314. ( PubMed , DOI )

  10. Daniel J Klionsky, etc.: Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition). Autophagy. 2021.02; 1-382. ( PubMed , DOI )

  1. Tanaka Hikari, Kondo Kanoh, Chen Xigui, Homma Hidenori, Tagawa Kazuhiko, Saido Takaomi, Muramatsu Shin-ichi, Fujita Kyota, Okazawa Hitoshi: 超早期アルツハイマー病においてSRRM2リン酸化はシナプス病理を誘発する(Phosphorylation of SRRM2 leads to synaptic pathology at ultra-early phase of Alzheimer's disease) 臨床神経学. 2020.11; 60 (Suppl.): S345. ( 医中誌 )

  2. Hiroto Yamamoto, Yutaro UchidaI, Tomoki Chiba, Ryota Kurimoto,Takahide Matsushima, Maiko Inotsume, Chihiro Ishikawa, Haiyan Li, Takashi Shiga, Masafumi Muratani, Tokujiro Uchida, Hiroshi Asahara: Transcriptome analysis of sevoflurane exposure effects at the different brain regions PLOS ONE. 2020.10;

  3. Yang SS, Ishida T, Fujita K, Nakai Y, Ono T, Okazawa H: PQBP1, an intellectual disability causative gene, affects bone development and growth. Biochem Biophys Res Commun. 2020.03; 523 (4): 894-899. ( PubMed , DOI )

  4. Yang SS, Ishida T, Fujita K, Nakai Y, Ono T, Okazawa H. : PQBP1, an intellectual disability causative gene, affects bone development and growth. Biochemical and Biophysical Research Communications.. 2020.03; 523 894-899. ( DOI )

  5. Tanaka H, Homma H, Fujita K, Kondo K, Yamada S, Jin X, Waragai M, Ohtomo G, Iwata A, Tagawa K, Atsuta N, Katsuno M, Tomita N, Furukawa K, Saito Y, Saito T, Ichise A, Shibata S, Arai H, Saido T, Sudol M, Muramatsu SI, Okano H, Mufson EJ, Sobue G, Murayama S, Okazawa H: YAP-dependent necrosis occurs in early stages of Alzheimer's disease and regulates mouse model pathology. Nat Commun . 2020.01; 11 (1): 507. ( PubMed , DOI )

  6. Tanaka H, Homma H, Fujita K, Kondo K, Yamada S, Jin X, Waragai M, Ohtomo G, Iwata A, Tagawa K, Atsuta N, Katsuno M, Tomita N, Furukawa K, Saito Y, Saito T, Ichise A, Shibata S, Arai H, Saido T, Sudol M, Muramatsu SI, Okano H, Mufson EJ, Sobue G, Murayama S, Okazawa H.: YAP-dependent necrosis occurs in early stages of Alzheimer's disease and regulates mouse model pathology. Nature Communications. 2020.01; 11 507. ( DOI )

  1. Fujita Kyota, Chen Xigui, Homma Hidenori, Tagawa Kazuhiko, Okazawa Hitoshi: Targeting Tyro3 ameliorates a model of PGRN-mutant FTLD-TDP via tau-mediated synaptic pathology(和訳中) 臨床神経学. 2019.11; 59 (Suppl.): S213. ( 医中誌 )

  2. Rahmn SK, Okazawa H, Chen YW: Frameshift PQBP-1 mutants K192Sfs*7 and R153Sfs*41 implicated in X-linked intellectual disability form stable dimers. Journal of Structural Biology. 2019.06; 206 (3): 305-313. ( PubMed , DOI )

  3. Bannai T, Mano T, Chen X, Ohtomo G, Ohtomo R, Tsuchida T, Koshi-Mano K, Hashimoto T, Okazawa H, Iwatsubo T, Tsuji S, Toda T, Iwata A: Chronic cerebral hypoperfusion shifts the equilibrium of amyloid beta oligomers to aggregation-prone species with higher molecular weight. Scientific Reports. 2019.02; 9 (1): 2827. ( PubMed , DOI )

  4. Chen X, Kondo K, Okazawa H: Methods to Image Macroautophagy in the Brain In Vivo. Methods Mol Biol. 2019.01; 1880 529-534. ( PubMed , DOI )

  5. Inoue S, Hayashi K, Fujita K, Tagawa K, Okazawa H, Kubo K, Nakajima K: Drebrin-like (Dbnl) controls neuronal migration via regulating N-cadherin expression in the developing cerebral cortex. Journal of Neuroscience. 2019.01; 39 (4): 678-691. ( PubMed , DOI )

  1. Fujita Kyota, Mao Ying, Uchida Shigenori, Chen Xigui, Shiwaku Hiroki, Tamura Takuya, Ito Hikaru, Homma Hidenori, Tagawa Kazuhiko, Okazawa Hitoshi: Developmental YAPdeltaC determines adult pathology in a mouse model of spinocerebellar ataxia type 1(和訳中) 臨床神経学. 2018.12; 58 (Suppl.): S200. ( 医中誌 )

  2. Hitoshi Okazawa: PQBP1, an intrinsically disordered/denatured protein at the crossroad of intellectual disability and neurodegenerative diseases. Neurochem Int. 2018.10; 119 17-25. ( PubMed , DOI )

  3. Tanaka H, Kondo K, Chen X, Homma H, Tagawa K, Kerever A, Aoki S, Saito T, Saido T, Muramatsu S, Fujita K, Okazawa H: The intellectual disability gene PQBP1 rescues Alzheimer's disease pathology. Mol psychiatry. 2018.10; 23 (10): 2090-2110. ( PubMed , DOI )

  4. Fujita K, Homma H, Kondo K, Ikuno M, Yamakado H, Tagawa K, Murayama S, Takahashi R, Okazawa H.: Ser46-Phosphorylated MARCKS Is a Marker of Neurite Degeneration at the Pre-aggregation Stage in PD/DLB Pathology. eNeuro. 2018.10; 5 (4): ENEURO.0217-18.2018.. ( DOI )

  5. Tanaka H, Kondo K, Chen X, Homma H, Tagawa K, Kerever A, Aoki S, Saito T, Saido T, Muramatsu SI, Fujita K, Okazawa H. : The intellectual disability gene PQBP1 rescues Alzheimer's disease pathology. Molecular Psychiatry. 2018.10; 23 2090-2110. ( DOI )

  6. Tamura T, Okazawa H: TRIAD(Transcriptional Repression-Induced Atypical Death) Apoptosis and Beyond. 2018.09; 2 411-426.

  7. Furotani K, Kamimura K, Yajima T, Nakayama M, Enomoto R, Tamura T, Okazawa H, Sone M: Suppression of the synaptic localization of a subset of proteins including APP partially ameliorates phenotypes of the Drosophila Alzheimer's disease model. PLoS ONE. 2018.09; 13 (9): e0204048. ( PubMed , DOI )

  8. Fujita K, Homma H, Kondo K, Ikuno M, Yamakado H, Tagawa K, Murayama S, Takahashi R, Okazawa H: Ser46-Phosphorylated MARCKS Is a Marker of Neurite Degeneration at the Pre-aggregation Stage in PD/DLB Pathology. eNeuro. 2018.07; 5 (4): ( PubMed , DOI )

  9. Hitoshi Okazawa: Bridging Multiple Dementias. ACS Chem Neurosci. 2018.04; 9 (4): 636-638. ( PubMed , DOI )

  10. Irie R, Kamagata K, Kerever A, Ueda R, Yokosawa S, Otake Y, Ochi H, Yoshizawa H, Hayashi A, Tagawa K, Okazawa H, Takahashi K, Sato K, Hori M, Arikawa-Hirasawa E, Aoki S: The Relationship between Neurite Density Measured with Confocal Microscopy in a Cleared Mouse Brain and Metrics Obtained from Diffusion Tensor and Diffusion Kurtosis Imaging. Magn Reson Med Sci. 2018.04; 17 (2): 138-144. ( PubMed , DOI )

  11. Kawahori K, Hashimoto K, Yuan X, Tsujimoto K, Hanzawa N, Hamaguchi M, Kase S, Fujita K, Tagawa K, Okazawa H, Nakajima Y, Shibusawa N, Yamada M, Ogawa Y: Mild Maternal Hypothyroxinemia During Pregnancy Induces Persistent DNA Hypermethylation in the Hippocampal Brain-Derived Neurotrophic Factor Gene in Mouse Offspring. Thyroid. 2018.03; 28 (3): 395-406. ( PubMed , DOI )

  12. Kawahori K, Hashimoto K, Yuan X, Tsujimoto K, Hanzawa N, Hamaguchi M, Kase S, Fujita K, Tagawa K, Okazawa H, Nakajima Y, Shibusawa N, Yamada M, Ogawa Y. : Mild Maternal Hypothyroxinemia During Pregnancy Induces Persistent DNA Hypermethylation in the Hippocampal Brain-Derived Neurotrophic Factor Gene in Mouse Offspring. Thyroid. 2018.03; 28 (3): 395-406. ( DOI )

  13. Kyota Fujita, Xigui Chen, Hidenori Homma, Kazuhiko Tagawa, Mutsuki Amano, Ayumu Saito, Seiya Imoto, Hiroyasu Akatsu, Yoshio Hashizume, Kozo Kaibuchi, Satoru Miyano, Hitoshi Okazawa: Targeting Tyro3 ameliorates a model of PGRN-mutant FTLD-TDP via tau-mediated synaptic pathology. Nat Commun. 2018.01; 9 (1): 433. ( PubMed , DOI )

  14. Fujita K, Chen X, Homma H, Tagawa K, Amano M, Saito A, Imoto S, Akatsu H, Hashizume Y, Kaibuchi K, Miyano S, Okazawa H. : Targeting Tyro3 ameliorates a model of PGRN-mutant FTLD-TDP via tau-mediated synaptic pathology. Nature Communications. 2018.01; 9 433. ( DOI )

  1. Fujita K, Mao Y, Uchida S, Chen X, Shiwaku H, Tamura T, Ito H, Watase K, Homma H, Tagawa K, Sudol M, Okazawa H: Developmental YAPdeltaC determines adult pathology in a model of spinocerebellar ataxia type 1. Nat Commun. 2017.11; 8 (1): 1864. ( PubMed , DOI )

  2. Chen X., Mao Y., Xu M., Fujita K., Motoki K., Sasabe T., Homma H., Tagawa K., Tamura T., Okazawa H.: Targeting tead/yap-transcription-dependent necrosis, triad, ameliorates Huntington's disease pathology JOURNAL OF THE NEUROLOGICAL SCIENCES. 2017.10; 381 219. ( DOI )

  3. Fujita K., Motoki K., Tagawa K., Chen X., Hama H., Nakajima K., Homma H., Tamura T., Miyawaki A., Okazawa H.: HMGB1 triggers neurite degeneration via TLR4-MARCKS, and is a potential therapeutic target for alzheimer's disease JOURNAL OF THE NEUROLOGICAL SCIENCES. 2017.10; 381 64-65. ( DOI )

  4. Hitoshi Okazawa: Ultra-Early Phase pathologies of Alzheimer's disease and other neurodegenerative diseases. Proc Jpn Acad Ser B Phys Biol Sci. 2017.06; 93 (6): 361-377. ( PubMed , DOI )

  5. Sato K, Kerever A, Kamagata K, Tsuruta K, Irie R, Tagawa K, Okazawa H, Arikawa-Hirasawa E, Nitta N, Aoki I, Aoki S: Understanding microstructure of the brain by comparison of neurite orientation dispersion and density imaging (NODDI) with transparent mouse brain. Acta Radiol Open. 2017.04; 6 (4): 2058460117703816. ( PubMed , DOI )

  6. Yamanishi E, Hasegawa K, Fujita K, Ichinose S, Yagishita S, Murata M, Tagawa K, Akashi T, Eishi Y, Okazawa H: A novel form of necrosis, TRIAD, occurs in human Huntington's disease. Acta Neuropathol Commun. 2017.03; 5 (1): 19. ( PubMed , DOI )

  1. Mao Y, Chen X, Xu M, Fujita K, Motoki K, Sasabe T, Homma H, Murata M, Tagawa K, Tamura T, Kaye J, Finkbeiner S, Blandino G, Sudol M, Okazawa H: Targeting TEAD/YAP-transcription-dependent necrosis, TRIAD, ameliorates Huntington's disease pathology. Human molecular genetics. 2016.11; 25 (21): 4749-4770. ( PubMed , DOI )

  2. Mao Y, Chen X, Xu M, Fujita K, Sasabe K, Homma H, Murata M, Tagawa K, Tamura T, Kaye J, Finkbeiner S, Blandino G, Sudol M, Okazawa H : Targeting TEAD/YAP-transcription-dependent necrosis, TRIAD, ameliorates Huntington's disease pathology. Hum Mol Genet. 2016.11; 25 (21): 4749-4770. ( PubMed , DOI )

  3. Kamagata K, Kerever A, Yokosawa S, Otake Y, Ochi H, Hori M, Kamiya K, Tsuruta K, Tagawa K, Okazawa H, Aoki S, Arikawa-Hirasawa E: Quantitative Histological Validation of Diffusion Tensor MRI with Two-Photon Microscopy of Cleared Mouse Brain. Magn Reson Med Sci. 2016.10; 15 (4): 416-421. ( PubMed , DOI )

  4. Taniguchi JB, Kondo K, Fujita K, Chen X, Homma H, Sudo T, Mao Y, Watase K, Tanaka T, Tagawa K, Tamura T, Muramatsu SI, Okazawa H: RpA1 ameliorates symptoms of mutant ataxin-1 knock-in mice and enhances DNA damage repair. Hum Mol Genet. 2016.10; 25 (20): 4432-4447. ( PubMed , DOI )

  5. Mao, Y., Chen, X., Xu, M.,Fujita, K., Sasabe, K.,Homma, H., Murata, M., Tagawa, K., Tamura, T., Kaye, J., Finkbeiner, S., Blandino, G., Sudol, M., Okazawa, H. : Targeting TEAD/YAP-transcription-dependent necrosis, TRIAD, ameliorates Huntington’s disease pathology. Hum Mol Genet.. 2016.09;

  6. Imamura T, Fujita K, Tagawa K, Ikura T, Chen X, Homma H, Tamura T, Mao Y, Taniguchi JB, Motoki K, Nakabayashi M, Ito N, Yamada K, Tomii K, Okano H, Kaye J, Finkbeiner S, Okazawa H: Identification of hepta-histidine as a candidate drug for Huntington's disease by in silico-in vitro- in vivo-integrated screens of chemical libraries. Sci Rep. 2016.09; 6 33861. ( PubMed , DOI )

  7. Tomomi Imamura, Kyota Fujita, Kazuhiko Tagawa, Teikichi Ikura, Xigui Chen, Hidenori Homma, Takuya Tamura, Ying Mao, Juliana Bosso Taniguchi, Kazumi Motoki, Makoto Nakabayashi, Nobutoshi Ito, Kazunori Yamada, Kentaro Tomii, Hideyuki Okano, Julia Kaye, Steven Finkbeiner, Hitoshi Okazawa: Identification of hepta-histidine as a candidate drug for Huntington's disease by in silico-in vitro- in vivo-integrated screens of chemical libraries. Sci Rep. 2016.09; 6 33861. ( PubMed , DOI )

  8. Fujita K, Motoki K, Tagawa K, Chen X, Hama H, Nakajima K, Homma H, Tamura T, Watanabe H, Katsuno M, Matsumi C, Kajikawa M, Saito T, Saido T, Sobue G, Miyawaki A, Okazawa H: HMGB1, a pathogenic molecule that induces neurite degeneration via TLR4-MARCKS, is a potential therapeutic target for Alzheimer's disease. Scientific reports. 2016.08; 6 31895. ( PubMed , DOI )

  9. Fujita K, Motoki K, Tagawa K, Chen X, Hama H, Nakajima K, Homma H, Tamura T, Watanabe H, Katsuno M, Matsumi C, Kajikawa M, Saito T, Saido T, Sobue G, Miyawaki A, Okazawa H: HMGB1, a pathogenic molecule that induces neurite degeneration via TLR4-MARCKS, is a potential therapeutic target for Alzheimer's disease. Sci Rep. 2016.08; 6 31895. ( PubMed , DOI )

  10. Mizuguchi M, Obita T, Kajiyama A, Kozakai Y, Nakai T, Nabeshima Y, Okazawa H: Allosteric modulation of the binding affinity between PQBP1 and the spliceosomal protein U5-15kD. FEBS Lett. 2016.07; 590 (14): 2221-2231. ( PubMed , DOI )

  11. Mao Y, Tamura T, Yuki Y, Abe D, Tamada Y, Imoto S, Tanaka H, Homma H, Tagawa K, Miyano S, Okazawa H: The hnRNP-Htt axis regulates necrotic cell death induced by transcriptional repression through impaired RNA splicing. Cell Death Dis. 2016.04; 7 (4): e2207. ( PubMed , DOI )

  1. Chen X, Kondo K, Motoki K, Homma H, Okazawa H: Fasting activates macroautophagy in neurons of Alzheimer's disease mouse model but is insufficient to degrade amyloid-beta. Scientific Reports. 2015.07; 5 12115. ( PubMed , DOI )

  2. Shiwaku H, Okazawa H: Impaired DNA damage repair as a common feature of neurodegenerative diseases and psychiatric disorders. Current Molecular Medicine. 2015.02; 15 (2): 119-128. ( PubMed , DOI )

  3. Hikaru Ito, Kyota Fujita, Kazuhiko Tagawa, Xigui Chen, Hidenori Homma, Toshikazu Sasabe, Jun Shimizu, Shigeomi Shimizu, Takuya Tamura, Shin-ichi Muramatsu, Hitoshi Okazawa: HMGB1 facilitates repair of mitochondrial DNA damage and extends the lifespan of mutant ataxin-1 knock-in mice. EMBO Mol Med. 2015.01; 7 (1): 78-101. ( PubMed , DOI )

  4. Tagawa K, Homma H, Saito A, Fujita K, Chen X, Imoto S, Oka T, Ito H, Motoki K, Yoshida C, Hatsuta H, Murayama S, Iwatsubo T, Miyano S, Okazawa H. : Comprehensive phosphoproteome analysis unravels the core signaling network that initiates the earliest synapse pathology in preclinical Alzheimer's disease brain. Human Molecular Genetics.. 2015.01; 24 540-558. ( DOI )

  1. Shiraishi R, Tamura T, Sone M, Okazawa H: Systematic analysis of fly models with multiple drivers reveals different effects of ataxin-1 and huntingtin in neuron subtype-specific expression. PLoS ONE. 2014.12; 9 (12): e116567. ( PubMed , DOI )

  2. Nabeshima Y, Mizuguchi M, Kajiyama A, Okazawa H: Segmental isotope-labeling of the intrinsically disordered protein PQBP1. FEBS Letters. 2014.12; 588 (24): 4583-4589. ( PubMed , DOI )

  3. Tagawa, K., Homma, H., Saito, A., Fujita, K., Chen, X., Imoto, S., Oka, T., Ito, H., Motoki, K., Yoshida, C., Hatsuta, H., Murayama, S., Iwatsubo, T., Miyano, S., Okazawa, H.: Comprehensive phosphoproteome analysis unravels the core signaling network that initiates the earliest synapse pathology in preclinical Alzheimer's disease brain. Hum Mol Genet. 2014.09; ( PubMed , DOI )

  4. Ito, H., Shiwaku, H., Yoshida, C., Homma, H., Luo, H., Chen, X., Fujita, K., Musante, L., Fischer, U., Frints, S G M., Romano, C., Ikeuchi, Y., Shimamura, T., Imoto, S., Miyano, S., Muramatsu, S-I., Kawauchi, T., Hoshino, M., Sudol, M., Arumughan, A., Wanker, E E., Rich, T., Schwartz, C., Matsuzaki, F., Bonni, A., Kalscheuer, V M., Okazawa, H.: In utero gene therapy rescues microcephaly caused by Pqbp1-hypofunction in neural stem progenitor cells. Mol Psychiatry. 2014.07; 20 (4): 459-71. ( PubMed , DOI )

  5. Mizuguchi M, Obita T, Serita T, Kojima R, Nabeshima Y, Okazawa H: Mutations in the PQBP1 gene prevent its interaction with the spliceosomal protein U5-15 kD. Nat Commun. 2014.04; 5 3822. ( PubMed , DOI )

  6. Barclay SS, Tamura T, Ito H, Fujita K, Tagawa K, Shimamura T, Katsuta A, Shiwaku H, Sone M, Imoto S, Miyano S, Okazawa H: Systems biology analysis of Drosophila in vivo screen data elucidates core networks for DNA damage repair in SCA1. Hum Mol Genet. 2014.03; 23 (5): 1345-1364. ( PubMed , DOI )

  1. Ikeuchi Y, de la Torre-Ubieta L, Matsuda T, Steen H, Okazawa H, Bonni A: The XLID protein PQBP1 and the GTPase Dynamin 2 define a signaling link that orchestrates ciliary morphogenesis in postmitotic neurons. Cell Rep. 2013.09; 4 (5): 879-889. ( PubMed , DOI )

  2. Shiwaku H, Yagishita S, Eishi Y, Okazawa H: Bergmann glia are reduced in spinocerebellar ataxia type 1. Neuroreport. 2013.08; 24 (11): 620-625. ( PubMed , DOI )

  3. Li C, Ito H, Fujita K, Shiwaku H, Qi Y, Tagawa K, Tamura T, Okazawa H: Sox2 transcriptionally regulates PQBP1, an intellectual disability-microcephaly causative gene, in neural stem progenitor cells. PLoS ONE. 2013.07; 8 (7): e68627. ( PubMed , DOI )

  4. Fujita K, Nakamura Y, Oka T, Ito H, Tamura T, Tagawa K, Sasabe T, Katsuta A, Motoki K, Shiwaku H, Sone M, Yoshida C, Katsuno M, Eishi Y, Murata M, Taylor JP, Wanker EE, Kono K, Tashiro S, Sobue G, La Spada AR, Okazawa H: A functional deficiency of TERA/VCP/p97 contributes to impaired DNA repair in multiple polyglutamine diseases. Nat Commun. 2013.05; 4 1816. ( PubMed , DOI )

  5. Tamura T, Sone M, Nakamura Y, Shimamura T, Imoto S, Miyano S, Okazawa H: A restricted level of PQBP1 is needed for the best longevity of Drosophila. Neurobiol Aging. 2013.01; 34 (1): 356.e11-356.e20. ( PubMed , DOI )

  1. Martin Rees, Christian Gorba, Cesira de Chiara, Tam T T Bui, Mitla Garcia-Maya, Alex F Drake, Hitoshi Okazawa, Annalisa Pastore, Dmitri Svergun, Yu Wai Chen: Solution model of the intrinsically disordered polyglutamine tract-binding protein-1. Biophys J. 2012.04; 102 (7): 1608-1616. ( PubMed , DOI )

  2. Nakamura Y, Tagawa K, Oka T, Sasabe T, Ito H, Shiwaku H, La Spada AR, Okazawa H: Ataxin-7 associates with microtubules and stabilizes the cytoskeletal network. Hum Mol Genet. 2012.03; 21 (5): 1099-1110. ( PubMed , DOI )

  1. Tamura T, Sone M, Iwatsubo T, Tagawa K, Wanker EE, Okazawa H: Ku70 alleviates neurodegeneration in Drosophila models of Huntington's disease. PLoS ONE. 2011.11; 6 (11): e27408. ( PubMed , DOI )

  2. Oka T, Tagawa K, Ito H, Okazawa H: Dynamic changes of the phosphoproteome in postmortem mouse brains. PLoS ONE. 2011.06; 6 (6): e21405. ( PubMed , DOI )

  1. Aoki Y, Nakamura A, Yokota T, Saito T, Okazawa H, Nagata T, Takeda SI: In-frame dystrophin following exon 51-skipping improves muscle pathology and function in the exon 52-deficient mdx mouse. Mol Ther. 2010.11; 18 (11): 1995-2005. ( PubMed , DOI )

  2. Tamura T, Horiuchi D, Chen YC, Sone M, Miyashita T, Saitoe M, Yoshimura N, Chiang AS, Okazawa H: Drosophila PQBP1 regulates learning acquisition at projection neurons in aversive olfactory conditioning. J. Neurosci. 2010.10; 30 (42): 14091-14101. ( PubMed , DOI )

  3. Konno M, Hamazaki TS, Fukuda S, Tokuhara M, Uchiyama H, Okazawa H, Okochi H, Asashima M: Efficiently differentiating vascular endothelial cells from adipose tissue-derived mesenchymal stem cells in serum-free culture. Biochem Biophys Res Commun. 2010.10; 400 (4): 461-465. ( PubMed , DOI )

  4. Honda S, Hayashi S, Imoto I, Toyama J, Okazawa H, Nakagawa E, Goto Y, Inazawa J: Copy-number variations on the X chromosome in Japanese patients with mental retardation detected by array-based comparative genomic hybridization analysis. J Hum Genet. 2010.09; 55 (9): 590-599. ( PubMed , DOI )

  5. Shiwaku H, Yoshimura N, Tamura T, Sone M, Ogishima S, Watase K, Tagawa K, Okazawa H: Suppression of the novel ER protein Maxer by mutant ataxin-1 in Bergman glia contributes to non-cell-autonomous toxicity. EMBO J. 2010.07; 29 (14): 2446-2460. ( PubMed , DOI )

  6. Takahashi M, Mizuguchi M, Shinoda H, Aizawa T, Demura M, Okazawa H, Kawano K: Polyglutamine tract-binding protein-1 binds to U5-15kD via a continuous 23-residue segment of the C-terminal domain. Biochim Biophys Acta. 2010.07; 1804 (7): 1500-1507. ( PubMed , DOI )

  7. Enokido Y, Tamura T, Ito H, Arumughan A, Komuro A, Shiwaku H, Sone M, Foulle R, Sawada H, Ishiguro H, Ono T, Murata M, Kanazawa I, Tomilin N, Tagawa K, Wanker EE, Okazawa H: Mutant huntingtin impairs Ku70-mediated DNA repair. J Cell Biol. 2010.05; 189 (3): 425-443. ( PubMed , DOI )

  1. Ito H, Yoshimura N, Kurosawa M, Ishii S, Nukina N, Okazawa H: Knock-down of PQBP1 impairs anxiety-related cognition in mouse. Hum Mol Genet. 2009.11; 18 (22): 4239-4254. ( PubMed , DOI )

  2. Chin JH, Shiwaku H, Goda O, Komuro A, Okazawa H: Neural stem cells express Oct-3/4. Biochem Biophys Res Commun. 2009.10; 388 (2): 247-251. ( PubMed , DOI )

  3. Takahashi M, Mizuguchi M, Shinoda H, Tomoyasu AT, Demura M, Okazawa H, Kawano K: Polyglutamine tract binding protein-1 is an intrinsically unstructured protein Biochim. Biophys. Acta. 2009.06; 1794 (6): 936-943. ( PubMed , DOI )

  4. Morimoto N, Nagai M, Miyazaki K, Kurata T, Takehisa Y, Ikeda Y, Kamiya T, Okazawa H, Abe K: Progressive decrease in the level of YAPdeltaCs, pro-survival isoforms of YAP, in the spinal cord of transgenic mouse carrying a mutant SOD1 gene J Neurosci Res. 2009.03; 87 (4): 928-936. ( PubMed )

  5. Sone M, Uchida A, Komatsu A, Suzuki E, Ibuki I, Asada M, Shiwaku H, Tamura T, Hoshino M, Okazawa H, Nabeshima Y: Loss of yata, a novel gene regulating the subcellular localization of APPL, induces deterioration of neural tissues and lifespan shortening. PLoS ONE. 2009.02; 4 (2): e4466. ( PubMed , DOI )

  6. Takahashi Keiko, Yoshina Sawako, Masashi Maekawa, Ito Wakana, Inoue Takao, Shiwaku Hiroki, Arai Hiroyuki, Mitani Shohei, Okazawa Hitoshi: Nematode Homologue of PQBP1, a Mental Retardation Causative Gene, Is Involved in Lipid Metabolism PLOS ONE. 2009.01; 4 (1): e4104. ( PubMed , DOI )

  7. Tamura T, Sone M, Yamashita M, Wanker EE, Okazawa H: Glial cell lineage expression of mutant ataxin-1 and huntingtin induces developmental and late-onset neuronal pathologies in Drosophila models. PLoS ONE. 2009.01; 4 (1): e4262. ( PubMed , DOI )

  1. Enokido Yasushi, Yoshitake Ayaka, Ito Hikaru, Okazawa Hitoshi: Age-dependent change of HMGB1 and DNA double-strand break accumulation in mouse brain BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2008.11; 376 (1): 128-133. ( PubMed , DOI )

  2. Inagaki R, Tagawa K, Qi ML, Enokido Y, Ito H, Tamura T, Shimizu S, Oyanagi K, Arai N, Kanazawa I, Wanker EE, Okazawa H: Omi / HtrA2 is relevant to the selective vulnerability of striatal neurons in Huntington's disease. Eur. J. Neurosci. 2008.07; 28 (1): 30-40. ( PubMed , DOI )

  1. Qi ML, Tagawa K, Enokido Y, Yoshimura N, Wada Y, Watase K, Ishiura S, Kanazawa I, Botas J, Saitoe M, Wanker EE, Okazawa H: Proteome analysis of soluble nuclear proteins reveals that HMGB1/2 suppress genotoxic stress in polyglutamine diseases. Nat Cell Biol. 2007.04; 9 (4): 402-414. ( PubMed , DOI )

  2. Tagawa K, Marubuchi S, Qi ML, Enokido Y, Tamura T, Inagaki R, Murata M, Kanazawa I, Wanker EE, Okazawa H: The induction levels of heat shock protein 70 differentiate the vulnerabilities to mutant huntingtin among neuronal subtypes. J Neurosci. 2007.01; 27 (4): 868-880. ( PubMed , DOI )

  1. Marubuchi S, Okuda T, Tagawa K, Enokido Y, Horiuchi D, Shimokawa R, Tamura T, Qi ML, Eishi Y, Watabe K, Shibata M, Nakagawa M, Okazawa H: Hepatoma-derived growth factor, a new trophic factor for motor neurons, is up-regulated in the spinal cord of PQBP-1 transgenic mice before onset of degeneration. J Neurochem. 2006.10; 99 (1): 70-83. ( PubMed , DOI )

  2. Yoshimura N, Horiuchi D, Shibata M, Saitoe M, Qi ML, Okazawa H: Expression of human PQBP-1 in Drosophila impairs long-term memory and induces abnormal courtship. FEBS Lett. 2006.04; 580 (9): 2335-2340. ( PubMed , DOI )

  3. Hoshino M, Qi ML, Yoshimura N, Miyashita T, Tagawa K, Wada Y, Enokido Y, Marubuchi S, Harjes P, Arai N, Oyanagi K, Blandino G, Sudol M, Rich T, Kanazawa I, Wanker EE, Saitoe M, Okazawa H: Transcriptional repression induces a slowly progressive atypical neuronal death associated with changes of YAP isoforms and p73. J Cell Biol. 2006.02; 172 (4): 589-604. ( PubMed , DOI )

  1. Enokido Y, Suzuki E, Iwasawa K, Namekata K, Okazawa H, Kimura H: Cystathionine beta-synthase, a key enzyme for homocysteine metabolism, is preferentially expressed in the radial glia/astrocyte lineage of developing mouse CNS FASEB J. 2005.11; 19 (13): 1854-1856. ( PubMed , DOI )

  2. Marubuchi S, Wada Y, Okuda T, Hara Y, Qi ML, Hoshino M, Nakagawa M, Kanazawa I, Okazawa H: PQBP -1 dysfunction induces cell death of neurons through mitochondrial stress. J Neurochem. 2005.11; 95 (3): 858-870. ( PubMed , DOI )

  3. Qi Y, Hoshino M, Wada Y, Marubuchi S, Yoshimura N, Kanazawa I, Shinomiya K, Okazawa H: PQBP-1 is expressed predominantly in the central nervous system during development. Eur J Neurosci. 2005.09; 22 (6): 1277-1286. ( PubMed , DOI )

  1. Okuda T, Tagawa K, Qi ML, Hoshio M, Ueda H, Kawano H, Kanazawa I, Muramatsu M, Okazawa H: Oct-3/4 repression accelerates differentiation of neural progenitor cells in vitro and in vivo. Brain Res Mol Brain Res. 2004.12; 132 (1): 18-30. ( PubMed , DOI )

  2. Tagawa K, Hoshino M, Okuda T, Ueda H, Hayashi H, Engemann S, Okado H, Ichikawa M, Wanker EE, Okazawa H: Distinct aggregation and cell death patterns among different types of primary neurons induced by mutant huntingtin protein. J Neurochem. 2004.05; 89 (4): 974-987. ( PubMed , DOI )

  3. Hoshino M, Tagawa K, Okuda T, Ueda H, Okazawa H : General transcriptional repression by polyglutamine disease proteins is not directly linked to the presence of inclusion bodies Biochem. Biophys. Res. Commun. 2004.01; 313 (1): 110-116. ( PubMed , DOI )

  1. Hoshino M, Tagawa K, Okuda T, Murata M, Oyanagi K, Arai N, Mizutani T, Kanazawa I, Wanker EE, Okazawa H : Histone deacetylase activity is retained in primary neurons expressing mutant huntingtin protein J. Neurochem. 2003.10; 87 (１): 257-267. ( PubMed , DOI )

  2. Busch A, Engemann S, Lurz R, Okazawa H, Lehrach H, Wanker EE: Mutant huntingtin promotes the fibrillogenesis of wild-type huntingtin: a potential mechanism for loss of huntingtin function in Huntington's disease. J Biol Chem. 2003.10; 278 (42): 41452-41461. ( PubMed , DOI )

  3. Okuda T, Hattori H, Takeuchi S, Shimizu J, Ueda H, Palvimo JJ, Kanazawa I, Kawano H, Nakagawa M, Okazawa H: PQBP-1 transgenic mice show a late-onset motor neuron disease-like phenotype. Hum Mol Genet. 2003.04; 12 (7): 711-725. ( PubMed , DOI )

  1. Enokido Y, Maruoka H, Hatanaka H, Kanazawa I, Okazawa H: PQBP-1 increases vulnerability to low potassium stress and represses transcription in primary cerebellar neurons Biochem. Biophys. Res. Commun. 2002.06; 294 (2): 268-271. ( PubMed , DOI )

  2. Okazawa H, Rich T, Chang A, Lin X, Waragai M, Kajikawa M, Enokido Y, Komuro A, Kato S, Shibata M, Hatanaka H, Mouradian MM, Sudol M, Kanazawa I: Interaction between mutant ataxin-1 and PQBP-1 affects transcription and cell death. Neuron. 2002.05; 34 (5): 701-713. ( PubMed , DOI )

  3. Ueda H, Goto J, Hashida H, Lin X, Oyanagi K, Kawano H, Zoghbi HY, Kanazawa I, Okazawa H: Enhanced SUMOylation in polyglutamine diseases. Biochem Biophys Res Commun. 2002.04; 293 (1): 307-313. ( PubMed , DOI )

  1. Shoji M, Iwakami N, Takeuchi S, Waragai M, Suzuki M, Kanazawa I, Lippa CF, Ono S, Okazawa H: JNK activation is associated with intracellular beta-amyloid accumulation. Brain Res Mol Brain Res. 2000.12; 85 (1-2): 221-233. ( PubMed , DOI )

  2. Waragai M, Junn E, Kajikawa M, Takeuchi S, Kanazawa I, Shibata M, Mouradian MM, Okazawa H: PQBP-1/Npw38, a nuclear protein binding to the polyglutamine tract, interacts with U5-15kD/dim1p via the carboxyl-terminal domain. Biochem Biophys Res Commun. 2000.07; 273 (2): 592-595. ( PubMed , DOI )

  1. Takeuchi S, I mafuku I, Waragai M, Roth C, Kanazawa I, Buettner R, Mouradian MM, Okazawa H : AP-2beta represses D(1A) dopamine receptor gene transcription in neuro2a cells Molecular Brain Research. 1999.12; 74 (1-2): 208-216. ( PubMed , DOI )

  2. Imafuku I, Masaki T, Waragai M, Takeuchi S, Kawabata M, Hirai S, Ohno S, Nee LE, Lippa CF, Kanazawa I, Imagawa M, Okazawa H: Presenilin 1 suppresses the function of c-Jun homodimers via interaction with QM/Jif-1. J Cell Biol. 1999.10; 147 (1): 121-134. ( PubMed , DOI )

  3. Waragai M, Lammers CH, Takeuchi S, Imafuku I, Udagawa Y, Kanazawa I, Kawabata M, Mouradian MM, Okazawa H: PQBP-1, a novel polyglutamine tract-binding protein, inhibits transcription activation by Brn-2 and affects cell survival. Hum Mol Genet. 1999.06; 8 (6): 977-987. ( PubMed , DOI )

  1. Imafuku I, Waragai M, Takeuchi S, Kanazawa I, Kawabata M, Mouradian MM, Okazawa H: Polar amino acid-rich sequences bind to polyglutamine tracts. Biochem Biophys Res Commun. 1998.12; 253 (1): 16-20. ( PubMed , DOI )

  2. Skala H, Porteu A, Thomas M, Szajnert MF, Okazawa H, Kahn A, Phan-Dinh-Tuy F: Upstream elements involved in vivo in activation of the brain-specific rat aldolase C gene. Role of binding sites for POU and winged helix proteins J Biol Chem. 1998.11; 273 (48): 31806-31814. ( PubMed , DOI )

  1. Waragai M, Imafuku I, Takeuchi S, Kanazawa I, Oyama F, Udagawa Y, Kawabata M, Okazawa H: Presenilin 1 binds to amyloid precursor protein directly. Biochem Biophys Res Commun. 1997.10; 239 (2): 480-482. ( PubMed , DOI )

  1. Okazawa H, Imafuku I, Minowa MT, Kanazawa I, Hamada H, Mouradian MM: Regulation of striatal D1A dopamine receptor gene transcription by Brn-4. Proc Natl Acad Sci USA. 1996.10; 93 (21): 11933-11938. ( PubMed , DOI )

  2. Imafuku I, Kamei M, Kanazawa I, Mouradian MM, Okazawa H : POU transcription factors differentially regulates the D1A dopamine receptor gene in cultured cells Biochem. Biophys. Res. Commun. 1996.05; 222 (3): 736-741. ( PubMed , DOI )

  3. Okazawa H, Shimizu J, Kamei M, Imafuku I, Hamada H, Kanazawa I: Bcl-2 inhibits retinoic acid-induced apoptosis during the neural differentiation of embryonal stem cells. J Cell Biol. 1996.03; 132 (5): 955-968. ( PubMed , DOI )

  1. Okazawa H, Kamei M, Imafuku I, Kanazawa I: Gene regulation of trkB and trkC in the chick retina by light/darkness exposure. Oncogene. 1994.07; 9 (7): 1813-1818. ( PubMed )

  1. Shimazaki T, Okazawa H, Fujii H, Ikeda M, Tamai K, McKay RD, Muramatsu M, Hamada H: Hybrid cell extinction and re-expression of Oct-3 function correlates with differentiation potential. EMBO J. 1993.12; 12 (12): 4489-4498. ( PubMed , DOI )

  2. Dechant G, Biffo S, Okazawa H, Kolbeck R, Pottgiesser J, Barde YA: Expression and binding characteristics of the BDNF receptor chick trkB. Development. 1993.10; 119 (2): 545-558. ( PubMed , DOI )

  3. Okazawa H, Kamei M and Kanazawa I : Molecular cloning and expression of a novel truncated form of chicken trkC FEBS letters. 1993.08; 329 (1-2): 171-177. ( PubMed , DOI )

  4. Okazawa H, Nishiyama K, Kamei M, Washizaki S, Murayama S, Kwak S and Kanazawa I: Trk immunoreactivity at neuronal dendrite and cell body Biochem. Biophys. Res. Commun. 1993.07; 194 (2): 683-690. ( PubMed , DOI )

  1. Okazawa H, Murata M, Watanabe M, Kamei M and Kanazawa I : Dopaminergic stimulation up-regulates the in vivo expression of brain derived neurotrophic factor (BDNF) in the striatum FEBS letters . 1992.11; 313 (2): 138-142. ( PubMed , DOI )

  1. Okazawa H, Okamoto K, Ishino F, Ishino-Kaneko T, Takeda S, Toyoda Y, Muramatsu M, Hamada H: The oct3 gene, a gene for an embryonic transcription factor, is controlled by a retinoic acid repressible enhancer. EMBO J. 1991.10; 10 (10): 2997-3005. ( PubMed , DOI )

  1. Okamoto K, Okazawa H, Okuda A, Sakai M, Muramatsu M, Hamada H: A novel octamer binding transcription factor is differentially expressed in mouse embryonic cells. Cell. 1990.02; 60 (3): 461-472. ( PubMed , DOI )

  1. 藤田 慶大, 岡澤 均: DNA損傷の修復と神経変性 AnnualReview神経2024. 2024.03; 35-41.

  1. 岡澤 均: 脊髄小脳失調症1型における遺伝子治療 脳神経内科. 2023.10; 99 (4): 542-550.

  2. 岡澤 均: DNA損傷と修復の疾患病態における役割 BIOClinica. 2023.08; 38 (9): 4-5.

  3. 田中 ひかり, 岡澤 均: DNA損傷と神経疾患 BIOClinica. 2023.08; 38 (9): 12-16.

  4. 田中 ひかり, 岡澤 均: 神経変性疾患における自然免疫応答 臨床免疫・アレルギー科. 2023.07; 80 (1): 56-62.

  5. 金 美花, 岡澤 均: ウイルス感染症と類似する神経変性疾患の炎症応答メカニズム 炎症と免疫. 2023.04; 31 (3): 26-33.

  6. 藤田 慶大, 岡澤 均: 脊髄小脳失調症1型 遺伝子治療開発研究ハンドブック第 2 版. 2023.04; 524-530.

  1. 岡澤 均, 藤田 慶大: 3塩基リピート病1(Huntington‘ｓDisease) メディカル・サイエンス・ダイジェスト. 2022.09; 48 (10): 3-5.

  2. 岡澤 均: 加齢, 変性疾患とDNA損傷修復不全 老年精神医学雑誌. 2022.06; 33 (6): 603-617.

  3. 望月 秀樹, 青木 正志, 池中 建介, 井上 治久, 岩坪 威, 宇川 義一, 岡澤 均, 小野 賢二郎, 小野寺 理, 北川 一夫, 齊藤 祐子, 下畑 享良, 髙橋 良輔, 戸田 達史, 中原 仁, 松本 理器, 水澤 英洋, 三井 純, 村山 繁雄, 勝野 雅央, 日本神経学会将来構想委員会, 青木 吉嗣, 石浦 浩之, 和泉 唯信, 小池 春樹, 島田 斉, 髙橋 祐二, 徳田 隆彦, 中嶋 秀人, 波田野 琢, 三澤 園子, 渡辺 宏久: 脳神経疾患克服に向けた研究推進の提言2020，各論I（方法論別) 臨床神経学. 2022.06; 62 (6): 429-442. ( PubMed , DOI )

  4. 望月 秀樹, 青木 正志, 池中 建介, 井上 治久, 岩坪 威, 宇川 義一, 岡澤 均, 小野 賢二郎, 小野寺 理, 北川 一夫, 齊藤 祐子, 下畑 享良, 髙橋 良輔, 戸田 達史, 中原 仁, 松本 理器, 水澤 英洋, 三井 純, 村山 繁雄, 勝野 雅央, 日本神経学会将来構想委員会, 青木 吉嗣, 石浦 浩之, 和泉 唯信, 小池 春樹, 島田 斉, 髙橋 祐二, 徳田 隆彦, 中嶋 秀人, 波田野 琢, 三澤 園子, 渡辺 宏久: 脳神経疾患克服に向けた研究推進の提言2020，各論II（疾患群別) 臨床神経学. 2022.06; 62 (6): 443-457. ( PubMed , DOI )

  5. 岡澤 均: 臨床をベースとする基礎研究者のキャリアパスとリーダーシップ BRAIN and NERVE. 2022.01; 74 (1): 59-62. ( DOI )

  6. 岡澤 均: Alzheimer病態に於ける細胞内アミロイド,細胞死,細胞外アミロイド凝縮の時間的関係 神経治療学. 2022.01; 38 (3): 347-352.

  1. 望月 秀樹, 青木 正志, 池中 建介, 井上 治久, 岩坪 威, 宇川 義一, 岡澤 均, 小野 賢二郎, 小野寺 理, 北川 一夫, 齊藤 祐子, 下畑 享良, 髙橋 良輔, 戸田 達史, 中原 仁, 松本 理器, 水澤 英洋, 三井 純, 村山 繁雄, 勝野 雅央, 青木 吉嗣, 石浦 浩之, 和泉 唯信, 小池 春樹, 島田 斉, 髙橋 祐二, 徳田 隆彦, 中嶋 秀人, 波田野 琢, 三澤 園子, 渡辺 宏久: 脳神経疾患克服に向けた研究推進の提言 2020，総論 臨床神経学. 2021.11; 61 (11): 709-721. ( PubMed , DOI )

  2. 味岡 逸樹, 岡澤 均: 東京医科歯科大学脳統合機能研究センター(CBIR) Clinical Neuroscience. 2021.10; 39 (10): 1232-1235.

  1. 岡澤 均: アルツハイマー病態に於ける細胞内アミロイド、細胞死、細胞外アミロイド凝縮の時間的関係 神経治療学. 2020.10; 37 (6): S119.

  2. 田中 ひかり, 近藤 和, 陳 西貴, 本間 秀典, 田川 一彦, 藤田 慶大, 岡澤 均: 発達障害原因遺伝子PQBP1はアルツハイマー病態を制御する Dementia Japan. 2020.10; 34 (4): 527. ( 医中誌 )

  3. 田中 ひかり, 本間 秀典, 藤田 慶大, 近藤 和, Jin Xiaocen, 田川 一彦, 岡澤 均: YAP依存的ネクローシスは超早期アルツハイマー病態を制御する Dementia Japan. 2020.10; 34 (4): 473. ( 医中誌 )

  4. 田中 ひかり, 岡澤 均: ダウンストリームを治療する 医学のあゆみ. 2020.04; 273 (1): 93-97.

  5. 田中 ひかり, 岡澤 均: 【神経変性疾患の治療開発の現状-新たな戦略構築の基盤をめざして】各分野の動向　ダウンストリームを治療する　神経細胞死 医学のあゆみ. 2020.04; 273 (1): 93-97. ( 医中誌 )

  6. 田中 ひかり, 岡澤 均: 脊髄小脳失調症 Clinical Neuroscience . 2020.03; 38 (3): 365-368.

  7. 田中 ひかり, 岡澤 均: 【よくわかる遺伝子治療-実用化の現状と展望】遺伝子治療各論　脊髄小脳失調症 Clinical Neuroscience. 2020.03; 38 (3): 365-368. ( 医中誌 )

  1. 岡澤 均: アルツハイマー病の遺伝子治療の可能性 認知神経科学. 2019.12; 21 155-165.

  2. 田中 ひかり, 近藤 和, 陳 西貴, 田川 一彦, Kerever Aurelian, 青木 茂樹, 斉藤 貴志, 西道 隆臣, 村松 慎一, 藤田 慶大, 岡澤 均: 発達障害原因遺伝子PQBP1はアルツハイマー病態を制御する 臨床神経学. 2019.11; 59 (Suppl.): S461. ( 医中誌 )

  3. 近藤 和, 藤田 慶大, 岡澤 均: 脊髄小脳失調症とYAPdeltaC Clinical Neuroscience . 2019.08; 37 (8): 1007-1010.

  4. 田中 ひかり, 岡澤 均: 発達障害原因遺伝子PQBP1はアルツハイマー病態を制御する ケミカルバイオロジー. 2019.06; 12 (1): 12.

  1. 岡澤 均: 総論 シナプス研究を加速する基礎臨床連携 細胞. 2018.12; 50 (14): 2-4.

  2. 藤田 慶大, 岡澤 均: 変性疾患におけるシナプス異常の新知見 細胞. 2018.12; 50 (14): 25-28.

  3. 藤田 慶大, 陳 西貴, 本間 秀典, 田川 一彦, 岡澤 均: アルツハイマー病と前頭側頭葉変性症に共通する異常タウリン酸化とシナプス障害 Dementia Japan. 2018.09; 32 (3): 431. ( 医中誌 )

  4. 藤田 慶大, 岡澤 均: 凝集前病態の解明に基づくアルツハイマー病の新規DMT 開発 アルツハイマー病 . 2018.08; 157-164.

  5. 本間 秀典, 岡澤 均: 【ニューロジェネティクス新時代　次世代シークエンサーが拓く新しい世界】 筋疾患・神経疾患のジェネティクス　ハンチントン病 Clinical Neuroscience. 2018.02; 36 (2): 213-215. ( 医中誌 )

  6. 本間 秀典, 岡澤 均: ハンチントン病 Clinical Neuroscience. 2018.02; 36 (2): 213-215.

  7. 本間 秀典, 岡澤 均: 【ニューロジェネティクス新時代 次世代シークエンサーが拓く新しい世界】筋疾患・神経疾患のジェネティクス ハンチントン病 Clinical Neuroscience. 2018.02; 36 (2): 213-215. ( 医中誌 )

  8. 津田 浩史, 岡澤 均: Huntington病 神経疾患最新の治療 2018-2020. 2018.01; 200-202.

  1. 藤田 慶大, 本木 和美, 田川 一彦, 陳 西貴, 本間 秀典, 岡澤 均: アルツハイマー病において神経突起変性を誘発するHMGB1-MARCKSリン酸化シグナル Dementia Japan. 2017.10; 31 (4): 562. ( 医中誌 )

  2. 藤田 慶大, 岡澤 均: ポリグルタミン病 運動失調のみかた、考えかた . 2017.09; 251-260.

  3. 藤田 慶大, 岡澤 均: HMGB1補充による脊髄小脳失調症1型に対する分子標的治療 Brain Nerve. 2017.08; 69 (8): 925-932. ( PubMed , DOI )

  4. 藤田 慶大, 岡澤 均: アミロイド凝集前の超早期病態とその抑制 認知症. 2017.07; 35 (12): 198-203.

  1. 岡澤 均: アルツハイマー病の“超早期”治療を可能にする分子メカニズムと治療薬開発 ファームステージ. 2016.12;

  2. 岡澤 均, 本木 和美: 1990年以後の神経栄養因子臨床試験からの知見と教訓 生体の科学 . 2016.08; 67 (4): 291-295.

  3. 岡澤 均: 「認知症・神経変性疾患の克服への挑戦」によせて 生体の科学. 2016.08; 67 (4): 280.

  4. 藤田 慶大, 岡澤 均: 変性疾患の共通分子病態 生体の科学. 2016.08; 67 (4): 309-313.

  1. 藤田 慶大, 岡澤 均: 神経変性疾患の共通病態としてのDNA損傷修復異常 Annual Review神経2015. 2015.01; 65-72.

  1. 田村 拓也, 岡澤 均: 神経変性疾患の細胞死とHippo pathway —神経変性はHippo pathwayで制御されるか？— 医学のあゆみ. 2014.11; 251 (5): 449-454.

  1. 田村 拓也,　岡澤 均: PolII特異的阻害薬、-アマニチンが引き起こす非特異的で緩慢な細胞死（TRIAD) 日本ケミカルバイオロジー学会機関紙「ケミカルバイオロジー(Chemical Biology)」. 2009.12; 4 (2): 3.

  2. 岡澤 均: TRIAD Brain and nerve . 2009.03; 61 285-292. ( PubMed )

  1. 岡澤 均: 神経変性はアポトーシスか?--YAPdeltaCによる神経細胞死制御 生化学. 2007.02; 79 157-162. ( PubMed )

このページの先頭へ▲